AI English summary of an SEC filing — figures as filed
The company completed the issuance of $500,000,000 in senior notes maturing in 2027 at 4.625%, $600,000,000 in senior notes maturing in 2029 at 4.850%, and $700,000,000 in senior notes maturing in 2035 at 5.150%. The sale closed on December 9, 2024.
Key points
AI summaryThe company completed the issuance of $500,000,000 in senior notes maturing in 2027 at 4.625%, $600,000,000 in senior notes maturing in 2029 at 4.850%, and $700,000,000 in senior notes maturing in 2035 at 5.150%. The sale closed on December 9, 2024.
Cencora said the 2027 and 2029 notes pay interest semiannually on June 15 and December 15 each year, beginning on June 15, 2025, and the 2035 notes pay interest semiannually on February 15 and August 15 each year, beginning on February 15, 2025. Each series may be redeemed at a make-whole price until about 1 months before maturity (for the 2035 notes, until November 15, 2034).
The company said that if the acquisition of Retina Consultants of America is not completed on or before August 5, 2025, or is terminated before that date, it will be required to redeem all of the notes at 101% of principal plus accrued and unpaid interest.
The company said that the $3.3 billion bridge financing commitments it secured on November 5, 2024 were reduced to $1.8 billion on November 26 after it entered into a $1.5 billion Term Credit Agreement. After receiving net cash proceeds from the note sale on December 9, it terminated the remaining $1.8 billion in commitments in full.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Cencora Completes Issuance of 2027, 2029 and 2035 Senior Notes
The company completed the issuance of $500,000,000 in senior notes maturing in 2027 at 4.625%, $600,000,000 in senior notes maturing in 2029 at 4.850%, and $700,000,000 in senior notes maturing in 2035 at 5.150%. The sale closed on December 9, 2024.
Source · Based on the filing body and exhibits
Interest Payment Timing and Optional Redemption Terms by Note Series
Cencora said the 2027 and 2029 notes pay interest semiannually on June 15 and December 15 each year, beginning on June 15, 2025, and the 2035 notes pay interest semiannually on February 15 and August 15 each year, beginning on February 15, 2025. Each series may be redeemed at a make-whole price until about 1 months before maturity (for the 2035 notes, until November 15, 2034).
Source · Based on the filing body and exhibits
Mandatory Redemption if Retina Consultants of America Acquisition Is Not Completed
The company said that if the acquisition of Retina Consultants of America is not completed on or before August 5, 2025, or is terminated before that date, it will be required to redeem all of the notes at 101% of principal plus accrued and unpaid interest.
Source · Based on the filing body and exhibits
Full Termination of $1.8 billion Bridge Financing Commitments
The company said that the $3.3 billion bridge financing commitments it secured on November 5, 2024 were reduced to $1.8 billion on November 26 after it entered into a $1.5 billion Term Credit Agreement. After receiving net cash proceeds from the note sale on December 9, it terminated the remaining $1.8 billion in commitments in full.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…